Trelagliptin succinate
1029877-94-8
0.98%
2026-08-07
Coenzymes,Inhibito,Enzymes,Zymogens,Substrates,Native Microorganism Creatine Amidinohydrolase
-
Product Description
-
Seller Information
-
Description
ProductName Trelagliptin succinate Cat No CEI-1562 Product Overview Trelagliptin is a long acting dipeptidyl peptidase-4 (DPP-4) inhibitor that is being developed for the treatment of type 2 diabetes (T2D). Two Phase II clinical studies have been completed with Efficacy and Safety of SYR-472 in Subjects With Type 2 Diabetes Mellitus. Phase III clinical studies with trelagliptin in Japan to evaluate its safety and efficacy in a once-weekly oral treatment regimen. Currently, all available DPP-4 inhibitors are dosed once-daily. A once-weekly treatment, such as trelagliptin, would provide patients with a convenient treatment alternative and has the potential to improve treatment compliance. CAS No 1029877-94-8 Molecular Weight 475.47 Purity 0.98 Storage Store at -20°C Synonyms SYR-472 succinate; SYR472 succinate; SYR 472 succinate Targets DPP-4 Molecular Formula C22H26FN5O6 Chemical Name 2-[[6-[(3R)-3-aminopiperidin-1-yl]-3-methyl-2,4-dioxopyrimidin-1-yl]methyl]-4-fluorobenzonitrile; butanedioic acid Solubility Soluble in DMSO Shipping Conditions Evaluation sample solution: ship with blue ice. All other available size: ship with RT, or blue ice upon request category Bulk Drug Intermediates(c1112) cas_num 1029877-94-8 Basic Info-
Product Name:
SYR-472
Other Name:SYR-472 succinate;Trelagliptin Succinate (SYR-472);SYR 111472 succinate;Trelagliptin succinat;SYR-472 Trelagliptin succinat;Trelagliptin succinate(SRY-472);Trelagliptin succinateSYR 111472 succinate;SRY-472
CAS No.:1029877-94-8
Molecular Formula:C18H20FN5O2.C4H6O4
InChIKeys:OGCNTTUPLQTBJI-XFULWGLBSA-N
Molecular Weight:475.477
Exact Mass:475.187
UNII:4118932Z90
DSSTox ID:DTXSID00145602
Categories:
Characteristics-
PSA:
168
XLogP3:1.23468
Appearance:White to off-white solid
Hazard IdentificationClassification of the substance or mixture
no data available
GHS label elements, including precautionary statements
Pictogram(s) no data available Signal word no data available
Hazard statement(s) no data available
Precautionary statement(s) Prevention no data available
Response no data available
Storage no data available
Disposal no data available
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Coenzymes,Inhibito,Enzymes,Zymogens,Substrates,Native Microorganism Creatine Amidinohydrolase
-
Location:
Shirley, New York 11967, USA
-
Payment Terms:
TT against copy of documents,D/P
-
Average lead Time:
15
-
Total Annual Revenue:
$1 million-$2.5 million
-
Year of Establishment:
2004
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product